Feifei Xu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Immunology top 10%
- Immunotherapy and Immune Responses
- interferon and immune responses
Papers in
-
- Glycosylation and Glycoproteins Research 12
- Advanced biosensing and bioanalysis techniques 6
- Epigenetics and DNA Methylation 6
- Oncology 16
- Peptidase Inhibition and Analysis 7
- Co-authors
- Yun Chen (26 shared papers)Xiaojuan Wang (6 shared papers)Hongxia Zhang (6 shared papers)Ting Yang (6 shared papers)Xiaojun Xia (6 shared papers)Zining Wang (5 shared papers)Peng Huang (5 shared papers)Mengyun Li (4 shared papers)
- Journals
- Acta Pharmacologica Sinica (5 papers)Analytical Chemistry (4 papers)Analytical and Bioanalytical Chemistry (3 papers)Clinica Chimica Acta (3 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Feifei Xu
73 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 352
- Immunology 395
- Molecular Biology 1.2k
- Oncology 362
- Cell Biology 152
Countries citing papers authored by Feifei Xu
This map shows the geographic impact of Feifei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Xu more than expected).
Fields of papers citing papers by Feifei Xu
This network shows the impact of papers produced by Feifei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Xu. The network helps show where Feifei Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through Toll-like receptor 4 signaling Hit paper breakdown → | 2021 | 213 |
| 2 | 2019 | 185 | |
| 3 | 2019 | 89 | |
| 4 | 2014 | 74 | |
| 5 | 2022 | 64 | |
| 6 | 2018 | 63 | |
| 7 | 2014 | 60 | |
| 8 | 2014 | 54 | |
| 9 | 2009 | 44 | |
| 10 | 2019 | 42 | |
| 11 | 2015 | 41 | |
| 12 | 2016 | 38 | |
| 13 | 2020 | 36 | |
| 14 | 2023 | 34 | |
| 15 | 2015 | 32 | |
| 16 | 2019 | 30 | |
| 17 | 2014 | 29 | |
| 18 | 2017 | 29 | |
| 19 | 2017 | 28 | |
| 20 | 2014 | 27 |
About Feifei Xu
Feifei Xu is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Spectroscopy, having authored 76 papers that have together received 1.8k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (12 papers), Advanced Proteomics Techniques and Applications (10 papers), Endoplasmic Reticulum Stress and Disease (8 papers), Peptidase Inhibition and Analysis (7 papers), Mass Spectrometry Techniques and Applications (7 papers), Advanced biosensing and bioanalysis techniques (6 papers), Epigenetics and DNA Methylation (6 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Cancer Research (352 citations), Immunology (395 citations), Molecular Biology (1.2k citations), Oncology (362 citations) and Cell Biology (152 citations). Feifei Xu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Yun Chen, Xiaojuan Wang, Hongxia Zhang, Ting Yang, Xiaojun Xia, Zining Wang, Peng Huang, Mengyun Li, Ting Yang and Yuan Sheng. Their work appears in journals such as Acta Pharmacologica Sinica, Analytical Chemistry, Analytical and Bioanalytical Chemistry, Clinica Chimica Acta and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.